POLB — Poolbeg Pharma Share News
0.000.00%
- £64.50m
- £52.33m
REG - Poolbeg Pharma PLC - Change of Registered Address
AnnouncementREG - Poolbeg Pharma PLC - Result of AGM
AnnouncementREG - Poolbeg Pharma PLC - Annual Report & AGM Notice
AnnouncementREG - Poolbeg Pharma PLC - Significant POLB 001 Patent Granted in USA
AnnouncementREG - Poolbeg Pharma PLC - Option Agreement to Acquire Orphan Drug Candidate
AnnouncementREG - Poolbeg Pharma PLC - Appointment of Joint Broker
AnnouncementREG - Poolbeg Pharma PLC - Results for the year ended 31 December 2023
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 US Patent Update
AnnouncementREG - Poolbeg Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Poolbeg Pharma PLC - Director Share Purchase
AnnouncementREG - Poolbeg Pharma PLC - Board Role Change and Launch of EIP
AnnouncementREG - Poolbeg Pharma PLC - Market Opportunity for POLB 001 for CRS
AnnouncementREG - Poolbeg Pharma PLC - Further data shows POLB001 potential in cancer CRS
AnnouncementREG - Poolbeg Pharma PLC - RSV AI Drug Candidate Analysis Update
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 Data Presented at ASH
AnnouncementREG - Poolbeg Pharma PLC - Directorate Change
AnnouncementRCS - Poolbeg Pharma PLC - Immunomodulator II patent granted in Japan
AnnouncementRCS - Poolbeg Pharma PLC - POLB 001 LPS Trial Data to be Presented at IUIS
AnnouncementREG - Poolbeg Pharma PLC - Former Amryt Pharma Leadership Team join Poolbeg
Announcement